MedTrace Logo

Study to Evaluate the Replacement of Reverse Transcriptase Nucleoside/Nucleotide Inhibitors by Nevirapine in Patients on Triple Treatment With Analogues Only

NCT00415090 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2008-10-31

No results posted yet for this study

Summary

The purpose of this study is to evaluate the proportion of patients with viral load of HIV-1 \< 50 copies after 48 weeks of follow-up after randomization to change or not to nevirapine.

Conditions

  • HIV Infections

Interventions

DRUG

Nevirapine

Switch one of ARV drugs to Nevirapine

Sponsors & Collaborators

  • Hospital de Calella

    lead OTHER

Principal Investigators

  • Josep Mª Llibre, MD,PhD · Hospital Sant Jaume de Calella

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-08-31
Primary Completion
2006-07-31
Completion
2006-07-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00415090 on ClinicalTrials.gov